In cancer, glutamate receptor overexpression is linked with the activation of different signaling pathways including PI3K/AKT/mTOR, Ras−MAPK−ERK, and MAPK/ERK, which are involved in the regulation of cell proliferation, survival leading to tumorigenesis (43, 54, 55). This evidence concerns the gene AKT1 and cancer.